Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
A Self-service rental system for paddle boards has been implemented on the Larvotto beach in Monaco. Users can access the equipment through a paying a...
Read More
French president Emmanuel Macron has called for stronger, more integrated European defences as he outlined his vision for a more assertive European Un...
Read More
The Côte d'Azur is on alert for a surge in imported cases of dengue fever. Since the beginning of 2024, a record 1,679 imported cases have been record...
Read More
The post-mortem will take place next Monday for a 33-year-old man whose body was recently found in the Var after being missing for more than a month....
Read More
French scientists have been developing technological tools for the past four years to help athletes optimize their training for the Paris 2024 Olympic...
Read More
